Z N Berneman
Overview
Explore the profile of Z N Berneman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clement J, Lee A, Verpooten G, Laenen L, Vergote V, De Samblanx H, et al.
Eur J Clin Microbiol Infect Dis
. 2017 Oct;
37(1):135-140.
PMID: 28986730
The European prototype of hantavirus, Puumala virus (PUUV), isolated from a common wild rodent, the bank vole (Myodes glareolus), causes nephropathia epidemica (NE). NE can perfectly mimic haemolytic-uraemic syndrome (HUS),...
2.
Van den Bergh J, Smits E, Versteven M, De Reu H, Berneman Z, Van Tendeloo V, et al.
J Immunol Res
. 2017 Aug;
2017:1975902.
PMID: 28785596
Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. In terms of overall survival, there is still room for...
3.
Van de Velde A, Beutels P, Smits E, Van Tendeloo V, Nijs G, Anguille S, et al.
Leuk Res
. 2016 Apr;
46:26-9.
PMID: 27111858
The advent of new cell-based immunotherapies for leukemia offers treatment possibilities for certain leukemia subgroups. The wider acceptability of these new technologies in clinical practice will depend on its impact...
4.
Nuyts A, Lee W, Bashir-Dar R, Berneman Z, Cools N
Mult Scler
. 2013 Feb;
19(8):995-1002.
PMID: 23369893
Many studies have demonstrated the role of the adaptive immune system in the pathogenesis of multiple sclerosis (MS). Recent data suggest that dendritic cells (DCs), which are innate immune cells,...
5.
Van De Velde A, Anguille S, Berneman Z
Acta Clin Belg
. 2013 Jan;
67(6):399-402.
PMID: 23340144
Therapeutic cancer vaccination, e.g. by using tumour antigen-presenting dendritic cells (DCs) that 'educate' the immune system to recognise and attack tumour cells, represents a new concept of treatment in oncology....
6.
Anguille S, Fujiki F, Smits E, Oji Y, Lion E, Oka Y, et al.
Leukemia
. 2012 Aug;
27(3):748-50.
PMID: 22929521
No abstract available.
7.
Anguille S, Van Tendeloo V, Berneman Z
Leukemia
. 2012 Jun;
26(10):2186-96.
PMID: 22652755
The graft-versus-leukemia effect of allogeneic hematopoietic stem cell transplantation (HSCT) has shown that the immune system is capable of eradicating acute myeloid leukemia (AML). This knowledge, along with the identification...
8.
Patteet L, Vermeulen K, Pieters K, Van Assche E, Vrelust I, Gaddiseur A, et al.
Acta Clin Belg
. 2012 Apr;
67(1):34-8.
PMID: 22480037
We report the case of a 46-year-old man who presented with the hypogranular variant of an acute promyelocytic leukaemia (APL). RT-PCR analysis for detection of the t(15;17) fusion transcript confirmed...
9.
Lion E, Willemen Y, Berneman Z, Van Tendeloo V, Smits E
Leukemia
. 2012 Mar;
26(9):2019-26.
PMID: 22446501
As central players of the innate immune system, natural killer (NK) cells can exert direct and indirect anti-tumor effects via their cytotoxic and immune regulatory capacities, pivotal in the induction...
10.
Anguille S, Lion E, Willemen Y, Van Tendeloo V, Berneman Z, Smits E
Leukemia
. 2011 Jan;
25(5):739-48.
PMID: 21274002
Interferon-α (IFN-α), a type I IFN, is a well-known antitumoral agent. The investigation of its clinical properties in acute myeloid leukemia (AML) has been prompted by its pleiotropic antiproliferative and...